Torasemide
CLINICAL USE
Loop diuretic: Hypertension Oedema
DOSE IN NORMAL RENAL FUNCTION
2.5–40 mg once daily (varies according to indication) Maximum dose: 200 mg daily
PHARMACOKINETICS
Molecular weight                           : 348.4 %Protein binding                           : >99 %Excreted unchanged in urine     : 25 Volume of distribution (L/kg)       : 0.09–0.331 half-life – normal/ESRD (hrs)      : 3–4/Unchanged DOSE IN RENAL IMPAIRMENT
GFR (mL/MIN)
20 to 50     : Dose as in normal renal function 10 to 20     : Dose as in normal renal function <10           : Dose as in normal renal function DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES
CAPD                : Unlikely to be dialysed. Dose as in normal renal function HD                     : Not dialysed. Dose as in normal renal function HDF/high flux   : Unknown dialysability. Dose as in normal renal function CAV/VVHD      : Not dialysed. Dose as in normal renal function IMPORTANT DRUG INTERACTIONS
Potentially hazardous interactions with other drugs Analgesics: increased risk of nephrotoxicity with NSAIDs; antagonism of diuretic effect with NSAIDs Anti-arrhythmics: risk of cardiac toxicity with anti-arrhythmics if hypokalaemia occurs; effects of lidocaine and mexiletine antagonised Antibacterials: increased risk of ototoxicity with aminoglycosides, polymyxins and vancomycin; avoid concomitant use with lymecycline Antidepressants: increased risk of hypokalaemia with reboxetine; enhanced hypotensive effect with MAOIs; increased risk of postural hypotension with tricyclics Anti-epileptics: increased risk of hyponatraemia with carbamazepine Antifungals: increased risk of hypokalaemia with amphotericin Antihypertensives: enhanced hypotensive effect; increased risk of first dose hypotensive effect with alpha-blockers; increased risk of ventricular arrhythmias with sotalol if hypokalaemia occurs Antipsychotics: increased risk of ventricular arrhythmias with amisulpride, sertindole or pimozide (avoid with pimozide) if hypokalaemia occurs; enhanced hypotensive effect with phenothiazines Atomoxetine: hypokalaemia increases risk of ventricular arrhythmias Cardiac glycosides: increased toxicity if hypokalaemia occurs Lithium: risk of toxicity ADMINISTRATION
Reconstition
– Route
Oral Rate of Administration
– Comments
– OTHER INFORMATION
Torasemide 10 mg is equivalent to furosemide 20–40 mg In patients with renal failure, the renal clearance is reduced but total plasma clearance is not significantly altered Approximately 80% of dose is excreted renally as parent drug and metabolites
See how to identify renal failure stages according to GFR calculation
See how to diagnose irreversible renal disease
Home